Tim Schultz, MD, PhD, FEBO
Show Description +
Tim Schultz, MD, PhD, FEBO, reviews data behind the safety and efficacy of the MINIject supraciliary MIGS device (iStar Medical) during a symposium at the European Glaucoma Society meeting. He shares his experience with the device and its outcome data demonstrating meaningful IOP reduction, mean reduction in medication, and minimal endothelial cell loss.
Posted: 7/16/2024
Tim Schultz, MD, PhD, FEBO
Tim Schultz, MD, PhD, FEBO, reviews data behind the safety and efficacy of the MINIject supraciliary MIGS device (iStar Medical) during a symposium at the European Glaucoma Society meeting. He shares his experience with the device and its outcome data demonstrating meaningful IOP reduction, mean reduction in medication, and minimal endothelial cell loss.
Posted: 7/16/2024
About iSTAR Medical
Visit us online: istarmed.com
Follow iSTAR Medical